Evidence for Steroid Control of the Metabolism of Profibrinolysin

Publisher Website
Google Scholar
Abstract
Daily therapy with 5 mg of norethynodrel and 0.075 mg of ethynylestra- diol-3-methyl ether (Enovid) is associated with a 34.7% (P < 0.001) increase in the activity of human serum profibrinolysin (plasminogen).
Funding Information
  • G. D. Searle and Co., Chicago Illinois
  • U.S. Public Health Service (H-3697)
  • American, Iowa and Minnesota Heart Associations; the Life Insurance Medical Research Fund; and the University of Minnesota Graduate School

This publication has 2 references indexed in Scilit: